Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Vogelmeier

Showing results (11-20 of 158) with videos related to

Pageof 16
Sort By:
Advances in Therapy|February 2, 2017
Erratum to: Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom ManagementDave Singh, Marc Miravitlles, Claus Vogelmeier
Advances in Therapy|December 17, 2016
Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom ManagementDave Singh, Marc Miravitlles, Claus Vogelmeier
Deutsche Medizinische Wochenschrift (1946)|February 1, 2019
[Perspectives 2025 - Positions of the German Society of Internal Medicine]Claus Vogelmeier, Jürgen Floege, Thomas Gamstätter
Orphanet Journal of Rare Diseases|September 26, 2013
Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approachRobert A Stockley, Marc Miravitlles, Claus Vogelmeier, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 4, 2004
Pulmonary abscess with bacteremia in a young manMarkus G Engelmann, Sigrid Nikol, Claus Vogelmeier
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2006
[Intermediate care units and noninvasive ventilation]Heinrich F Becker, Bernd Schönhofer, Claus Vogelmeier
International Journal of Chronic Obstructive Pulmonary Disease|March 4, 2016
Highlights and hot topics in the management of COPD: where are we heading?Alvar Agustí, Paul W Jones, Claus Vogelmeier
Innere Medizin (Heidelberg, Germany)|October 5, 2023
[Artificial intelligence : What constitutes good medicine?]Martin C Hirsch, Edouard Battegay, Claus Vogelmeier
American Journal of Respiratory and Critical Care Medicine|October 21, 2006
Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary diseasePeter Kardos, Marion Wencker, Thomas Glaab, et al.
Innere Medizin (Heidelberg, Germany)|March 2, 2026
[Tobacco and nicotine prevention-Safeguarding the future of Germany]Stefan Andreas, Christian Taube, Claus Vogelmeier, et al.
Pageof 16

Showing results (11-20 of 158) with videos related to

Sort By:
Pageof 16
Advances in Therapy|February 2, 2017
Erratum to: Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom ManagementDave Singh, Marc Miravitlles, Claus Vogelmeier
Advances in Therapy|December 17, 2016
Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom ManagementDave Singh, Marc Miravitlles, Claus Vogelmeier
Deutsche Medizinische Wochenschrift (1946)|February 1, 2019
[Perspectives 2025 - Positions of the German Society of Internal Medicine]Claus Vogelmeier, Jürgen Floege, Thomas Gamstätter
Orphanet Journal of Rare Diseases|September 26, 2013
Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approachRobert A Stockley, Marc Miravitlles, Claus Vogelmeier, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 4, 2004
Pulmonary abscess with bacteremia in a young manMarkus G Engelmann, Sigrid Nikol, Claus Vogelmeier
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2006
[Intermediate care units and noninvasive ventilation]Heinrich F Becker, Bernd Schönhofer, Claus Vogelmeier
International Journal of Chronic Obstructive Pulmonary Disease|March 4, 2016
Highlights and hot topics in the management of COPD: where are we heading?Alvar Agustí, Paul W Jones, Claus Vogelmeier
Innere Medizin (Heidelberg, Germany)|October 5, 2023
[Artificial intelligence : What constitutes good medicine?]Martin C Hirsch, Edouard Battegay, Claus Vogelmeier
American Journal of Respiratory and Critical Care Medicine|October 21, 2006
Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary diseasePeter Kardos, Marion Wencker, Thomas Glaab, et al.
Innere Medizin (Heidelberg, Germany)|March 2, 2026
[Tobacco and nicotine prevention-Safeguarding the future of Germany]Stefan Andreas, Christian Taube, Claus Vogelmeier, et al.
Pageof 16